Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1986 Dec;45(12):991–995. doi: 10.1136/ard.45.12.991

Evidence for oligoclonal B cell expansion in the peripheral blood of patients with rheumatoid arthritis.

D A Fox, B R Smith
PMCID: PMC1002038  PMID: 3101621

Abstract

Peripheral blood lymphocytes from patients with rheumatoid arthritis and osteoarthritis were examined for evidence of oligoclonal B cell expansion using the computer assisted flow cytometric technique of kappa-lambda (kappa-lambda) analysis. Eleven of 29 patients with rheumatoid arthritis but only one of 16 with osteoarthritis gave abnormal results (p less than 0.025). Abnormal kappa-lambda determinations did not correlate with age, duration of disease, presence of rheumatoid factor, or other clinical and laboratory parameters. Therapy with oral or intramuscular gold compounds appeared to diminish the incidence of kappa-lambda abnormality. These findings may indicate defective control of clonal B cell proliferation in rheumatoid arthritis.

Full text

PDF
991

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Al-Balaghi S., Ström H., Möller E. High incidence of spontaneous Ig-producing lymphocytes in peripheral blood and synovial fluid of patients with active seropositive rheumatoid arthritis. Scand J Immunol. 1982 Jul;16(1):69–76. doi: 10.1111/j.1365-3083.1982.tb00700.x. [DOI] [PubMed] [Google Scholar]
  2. Ault K. A. Detection of small numbers of monoclonal B lymphocytes in the blood of patients with lymphoma. N Engl J Med. 1979 Jun 21;300(25):1401–1405. doi: 10.1056/NEJM197906213002501. [DOI] [PubMed] [Google Scholar]
  3. Bardwick P. A., Bluestein H. G., Zvaifler N. J., Depper J. M., Seegmiller J. E. Altered regulation of Epstein-Barr virus induced lymphoblast proliferation in rheumatoid arthritis lymphoid cells. Arthritis Rheum. 1980 Jun;23(6):626–632. doi: 10.1002/art.1780230603. [DOI] [PubMed] [Google Scholar]
  4. Bell D. A., Pinto J. Distribution of activated B lymphocytes in the circulation and synovial fluid in rheumatoid arthritis. Clin Immunol Immunopathol. 1984 May;31(2):272–281. doi: 10.1016/0090-1229(84)90247-2. [DOI] [PubMed] [Google Scholar]
  5. Bellamy N., Cairns E., Bell D. A. Immunoregulation in rheumatoid arthritis: evaluation of T lymphocyte function in the control of polyclonal immunoglobulin synthesis in vitro. J Rheumatol. 1983 Feb;10(1):19–27. [PubMed] [Google Scholar]
  6. Carson D. A., Fong S. A common idiotope on human rheumatoid factors identified by a hybridoma antibody. Mol Immunol. 1983 Oct;20(10):1081–1087. doi: 10.1016/0161-5890(83)90116-5. [DOI] [PubMed] [Google Scholar]
  7. Cecere F., Lessard J., McDuffy S., Pope R. M. Evidence for the local production and utilization of immune reactants in rheumatoid arthritis. Arthritis Rheum. 1982 Nov;25(11):1307–1313. doi: 10.1002/art.1780251106. [DOI] [PubMed] [Google Scholar]
  8. Chen P. P., Goñi F., Fong S., Jirik F., Vaughan J. H., Frangione B., Carson D. A. The majority of human monoclonal IgM rheumatoid factors express a "primary structure-dependent" cross-reactive idiotype. J Immunol. 1985 May;134(5):3281–3285. [PubMed] [Google Scholar]
  9. Depper J. M., Bluestein H. G., Zvaifler N. J. Impaired regulation of Epstein-Barr virus-induced lymphocyte proliferation in rheumatoid arthritis is due to a T cell defect. J Immunol. 1981 Nov;127(5):1899–1902. [PubMed] [Google Scholar]
  10. Depper J. M., Zvaifler N. J. Epstein-Barr virus. Its relationship to the pathogenesis of rheumatoid arthritis. Arthritis Rheum. 1981 Jun;24(6):755–761. doi: 10.1002/art.1780240601. [DOI] [PubMed] [Google Scholar]
  11. Díaz-Jouanen E., Ruíz-Argüelles G. J., Vega-Ortíz J. M., Villareal G., Alarcón-Segovia D. From benign polyclonal to malignant monoclonal lymphoproliferation in a patient with primary Sjögren's syndrome. Arthritis Rheum. 1981 Jun;24(6):850–853. doi: 10.1002/art.1780240613. [DOI] [PubMed] [Google Scholar]
  12. Egeland T., Lea T., Mellbye O. J. T-cell immunoregulatory functions in rheumatoid arthritis patients. Scand J Immunol. 1983 Oct;18(4):355–362. doi: 10.1111/j.1365-3083.1983.tb01807.x. [DOI] [PubMed] [Google Scholar]
  13. Hakulinen T., Isomaki H., Knekt P. Rheumatoid arthritis and cancer studies based on linking nationwide registries in Finland. Am J Med. 1985 Jan 21;78(1A):29–32. doi: 10.1016/0002-9343(85)90242-6. [DOI] [PubMed] [Google Scholar]
  14. Hasler F., Bluestein H. G., Zvaifler N. J., Epstein L. B. Analysis of the defects responsible for the impaired regulation of EBV-induced B cell proliferation by rheumatoid arthritis lymphocytes. II. Role of monocytes and the increased sensitivity of rheumatoid arthritis lymphocytes to prostaglandin E. J Immunol. 1983 Aug;131(2):768–772. [PubMed] [Google Scholar]
  15. Hobbs M. V., Morgan E. L., Baker N. L., Weigle W. O. Regulation of antibody responses by rheumatoid factor. I. Polyclonal activation of human B cells by rheumatoid factor-containing preparations from seropositive plasma. J Immunol. 1985 Jan;134(1):223–229. [PubMed] [Google Scholar]
  16. Hoffman W. L., Douglass R. R., Smiley J. D. Synthesis of electrophoretically restricted IgG by cultured rheumatoid synovium. Arthritis Rheum. 1984 Sep;27(9):976–984. doi: 10.1002/art.1780270903. [DOI] [PubMed] [Google Scholar]
  17. Jasin H. E. Autoantibody specificities of immune complexes sequestered in articular cartilage of patients with rheumatoid arthritis and osteoarthritis. Arthritis Rheum. 1985 Mar;28(3):241–248. doi: 10.1002/art.1780280302. [DOI] [PubMed] [Google Scholar]
  18. KUNKEL H. G., MULLER-EBERHARD H. J., FUDENBERG H. H., TOMASI T. B. Gamma globulin complexes in rheumatoid arthritis and certain other conditions. J Clin Invest. 1961 Jan;40:117–129. doi: 10.1172/JCI104224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kinlen L. J. Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment. Am J Med. 1985 Jan 21;78(1A):44–49. doi: 10.1016/0002-9343(85)90245-1. [DOI] [PubMed] [Google Scholar]
  20. Ledford D. K., Goñi F., Pizzolato M., Franklin E. C., Solomon A., Frangione B. Preferential association of kappa IIIb light chains with monoclonal human IgM kappa autoantibodies. J Immunol. 1983 Sep;131(3):1322–1325. [PubMed] [Google Scholar]
  21. Ligler F. S., Smith R. G., Kettman J. R., Hernandez J. A., Himes J. B., Vitetta E. S., Uhr J. W., Frenkel E. P. Detection of tumor cells in the peripheral blood of nonleukemic patients with B-cell lymphoma: analysis of "clonal excess". Blood. 1980 May;55(5):792–801. [PubMed] [Google Scholar]
  22. Moutsopoulos H. M., Costello R., Drosos A. A., Mavridis A. K., Papadopoulos N. M. Demonstration and identification of monoclonal proteins in the urine of patients with Sjögren's syndrome. Ann Rheum Dis. 1985 Feb;44(2):109–112. doi: 10.1136/ard.44.2.109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Moutsopoulos H. M., Steinberg A. D., Fauci A. S., Lane H. C., Papadopoulos N. M. High incidence of free monoclonal lambda light chains in the sera of patients with Sjogren's syndrome. J Immunol. 1983 Jun;130(6):2663–2665. [PubMed] [Google Scholar]
  24. Olsen N. J., Jasin H. E. Decreased pokeweed mitogen-induced IgM and IgM rheumatoid factor synthesis in rheumatoid arthritis patients treated with gold sodium thiomalate or penicillamine. Arthritis Rheum. 1984 Sep;27(9):985–994. doi: 10.1002/art.1780270904. [DOI] [PubMed] [Google Scholar]
  25. Pardo I., Levinson A. I. Circulating immunoglobulin-secreting cells in rheumatoid arthritis. Clin Immunol Immunopathol. 1983 Oct;29(1):29–34. doi: 10.1016/0090-1229(83)90004-1. [DOI] [PubMed] [Google Scholar]
  26. Prior P., Symmons D. P., Hawkins C. F., Scott D. L., Brown R. Cancer morbidity in rheumatoid arthritis. Ann Rheum Dis. 1984 Apr;43(2):128–131. doi: 10.1136/ard.43.2.128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Romain P. L., Burmester G. R., Enlow R. W., Winchester R. J. Multiple abnormalities in immunoregulatory function of synovial compartment T cells in patients with rheumatoid arthritis. Recognition of a helper augmentation effect. Rheumatol Int. 1982;2(3):121–127. doi: 10.1007/BF00541164. [DOI] [PubMed] [Google Scholar]
  28. Smith B. R., Robert N. J., Ault K. A. In Waldenstrom's macroglobulinemia the quantity of detectable circulating monoclonal B lymphocytes correlates with clinical course. Blood. 1983 May;61(5):911–914. [PubMed] [Google Scholar]
  29. Smith B. R., Weinberg D. S., Robert N. J., Towle M., Luther E., Pinkus G. S., Ault K. A. Circulating monoclonal B lymphocytes in non-Hodgkin's lymphoma. N Engl J Med. 1984 Dec 6;311(23):1476–1481. doi: 10.1056/NEJM198412063112304. [DOI] [PubMed] [Google Scholar]
  30. Strand V., Talal N. Advances in the diagnosis and concept of Sjögren's syndrome (autoimmune exocrinopathy). Bull Rheum Dis. 1979;30(9):1046–1052. [PubMed] [Google Scholar]
  31. Symmons D. P., Ahern M., Bacon P. A., Hawkins C. F., Amlot P. L., Jones E. L., Prior P., Scott D. L. Lymphoproliferative malignancy in rheumatoid arthritis: a study of 20 cases. Ann Rheum Dis. 1984 Apr;43(2):132–135. doi: 10.1136/ard.43.2.132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Symmons D. P. Neoplasms of the immune system in rheumatoid arthritis. Am J Med. 1985 Jan 21;78(1A):22–28. doi: 10.1016/0002-9343(85)90241-4. [DOI] [PubMed] [Google Scholar]
  33. Tosato G., Steinberg A. D., Blaese R. M. Defective EBV-specific suppressor T-cell function in rheumatoid arthritis. N Engl J Med. 1981 Nov 19;305(21):1238–1243. doi: 10.1056/NEJM198111193052102. [DOI] [PubMed] [Google Scholar]
  34. Vaughan J. H. Immune system in rheumatoid arthritis: possible implications in neoplasms. Am J Med. 1985 Jan 21;78(1A):6–11. doi: 10.1016/0002-9343(85)90238-4. [DOI] [PubMed] [Google Scholar]
  35. Weinberg D. S., Pinkus G. S., Ault K. A. Cytofluorometric detection of B cell clonal excess: a new approach to the diagnosis of B cell lymphoma. Blood. 1984 May;63(5):1080–1087. [PubMed] [Google Scholar]
  36. Wernick R., Merryman P., Jaffe I., Ziff M. IgG and IgM rheumatoid factors in rheumatoid arthritis. Quantitative response to penicillamine therapy and relationship to disease activity. Arthritis Rheum. 1983 May;26(5):593–598. doi: 10.1002/art.1780260503. [DOI] [PubMed] [Google Scholar]
  37. Youinou P. Y., Irving W. L., Shipley M., Hayes J., Lydyard P. M. Evidence for B cell activation in patients with active rheumatoid arthritis. Clin Exp Immunol. 1984 Jan;55(1):91–98. [PMC free article] [PubMed] [Google Scholar]
  38. Zawadzki Z. A., Benedek T. G. Rheumatoid arthritis, dysproteinemic arthropathy, and paraproteinemia. Arthritis Rheum. 1969 Dec;12(6):555–568. doi: 10.1002/art.1780120603. [DOI] [PubMed] [Google Scholar]
  39. Zulman J., Jaffe R., Talal N. Evidence that the malignant lymphoma of Sjögren's syndrome is a monoclonal B-cell neoplasm. N Engl J Med. 1978 Nov 30;299(22):1215–1220. doi: 10.1056/NEJM197811302992204. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES